12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant movements. NeuBase Therapeutics, Aptevo Therapeutics, Galera Therapeutics, Alzamend Neuro, Asensus Surgical, and cbdMD were among the gainers, with increases ranging from 5.24% to 11.1%. Conversely, Acutus Medical, HeartBeam, Mustang Bio, Palisade Bio, Trevena, and Monopar Therapeutics saw declines between 5.0% and 16.4%.
May 03, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acutus Medical shares declined by 16.4% to $0.12, with a market cap of $3.5 million.
The sharp decline in AFIB's stock price could reflect negative investor sentiment or adverse developments, impacting its short-term market performance.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
HeartBeam stock decreased by 10.36% to $1.98, with a market cap of $52.1 million.
HeartBeam's after-market drop suggests potential concerns among investors, possibly due to company-specific news or broader market shifts affecting the sector.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Aptevo Therapeutics shares increased by 7.17% to $1.06, with a market cap of $3.8 million.
APVO's after-market rise indicates a positive market reaction, possibly driven by recent developments within the company or favorable conditions in the healthcare market.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
NeuBase Therapeutics stock increased by 11.1% to $0.45, with a market value of $1.6 million.
The significant after-market gain for NBSE suggests positive investor sentiment, potentially due to company-specific news or broader market trends affecting the healthcare sector.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90